![Bradford C. Sippy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Bradford C. Sippy
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bradford C. Sippy via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Thomas Jefferson University | College/University | Undergraduate Degree | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
SIRONA BIOCHEM CORP. | Pharmaceuticals: Major | Director/Board Member | |
Brighton Biotech, Inc.
![]() Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
University of Virginia | College/University | Doctorate Degree | |
Franz Haniel & Cie. GmbH
![]() Franz Haniel & Cie. GmbH Investment ManagersFinance Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany. | Investment Managers | Private Equity Analyst | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lehigh University | College/University | Masters Business Admin | |
Towson University | College/University | Undergraduate Degree | |
University of Wisconsin | College/University | Graduate Degree | |
Nabriva Therapeutics GmbH
![]() Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Friedrich Schiller University of Jena | College/University | Undergraduate Degree | |
CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | ||
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
Crossover Health, Inc.
![]() Crossover Health, Inc. Medical/Nursing ServicesHealth Services Crossover Health, Inc. provides worksite health and wellness services. It offers primary, ancillary, and advanced services, includes urgent care, occupational health, preventive care, chronic disease management, health risk assessment, health education, health coaching, biometrics, physical therapy, chiropractic, acupuncture, specialist preferred network, care coordination, health analytics, and remote care. The company was founded by Scott Shreeve in 2010 and is headquartered in Aliso Viejo, CA. | Medical/Nursing Services | Director/Board Member | |
UNC School of Medicine | College/University | Corporate Officer/Principal | |
BlackThorn Therapeutics, Inc.
![]() BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Pamlico BioPharma, Inc.
![]() Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Biotechnology | Director/Board Member | |
Wave Life Sciences USA, Inc.
![]() Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
Perseus Holdings USA LLC
![]() Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
Boston Pharmaceuticals, Inc.
![]() Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Cardior Pharmaceuticals GmbH
![]() Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Alladapt Immunotherapeutics, Inc.
![]() Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Exacis Biotherapeutics, Inc.
![]() Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
EQT Life Sciences Group BV
![]() EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
Corium LLC
![]() Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Biotechnology | Director/Board Member | |
EQT Life Sciences (Munich) | Investment Managers | Consultant / Advisor | |
Gurnet Point Capital LLC
![]() Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst |
Statistieken
Internationaal
Verenigde Staten | 38 |
Canada | 6 |
Duitsland | 5 |
Singapore | 2 |
Oostenrijk | 2 |
Sectoraal
Health Technology | 32 |
Consumer Services | 8 |
Finance | 5 |
Health Services | 4 |
Distribution Services | 3 |
Operationeel
Director/Board Member | 34 |
Independent Dir/Board Member | 8 |
Corporate Officer/Principal | 7 |
Undergraduate Degree | 5 |
Chairman | 5 |
Sterkste connecties
Insiders | |
---|---|
Mark Corrigan | 29 |
David S. Moore | 13 |
Travis Wilson | 9 |
Christoph Broja | 7 |
Chris Fanale | 1 |
Travis Helm | 1 |
James Singleton | 1 |
- Beurs
- Insiders
- Bradford C. Sippy
- Bedrijfsconnecties